Novel Coronavirus (SARS-CoV-2/COVID-19)
Food and Drug Administration staff provided their analysis of Johnson & Johnson’s COVID-19 booster application, indicating that a second dose provides substantially more protection against SAR-CoV-2 than the initial shot.
The Centers for Disease Control and Prevention (CDC) has released an initial document intended to assist jurisdictions across the country in planning for the distribution and administration of COVID-19 vaccines to the pediatric population. The document provides initial information pertaining to…
The Centers for Disease Control and Prevention has released an initial document intended to assist jurisdictions across the country in planning for the distribution and administration of COVID-19 vaccines to the pediatric population.
The Health Resources and Services Administration Oct. 13 will host the third in a series of webinar sessions on how to apply for a portion of $25.5 billion in COVID-19 relief funds
Merck announced its submission for a Food and Drug Administration emergency use authorization of its investigational oral antiviral COVID-19 medicine.
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response issued details on several key changes related to the REGEN-COV COVID-19 monoclonal antibody therapy.
Experts break down what to expect, misconceptions and protective measures to take.
Hospitals and health systems are paying $24 billion more per year for clinical labor than they did before the COVID-19 pandemic, according to an analysis released by Premier.
The Centers for Medicare & Medicaid Services has modified its COVID-19 blanket waiver for Medicare-dependent hospitals (MDHs) to include hospitals that became newly classified as MDHs during the COVID-19 public health emergency.
The AHA released a new issue of the COVID-19 Snapshot, underscoring the persisting challenges facing hospitals and health systems during the ongoing public health emergency.